Black:White disparities in lung cancer mortality in the 50 largest cities in the United States

Cancer Epidemiology

Volumn 39, Issue 6, 2015, Pages 908-916

  Hunt, Bijou ^a   Balachandran, Banujan ^b  

^a MOUNT SINAI HEALTH SYSTEM   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Big cities; Lung cancer; Racial disparities

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; BLACK PERSON; BRONCHUS CANCER; CANCER INCIDENCE; CANCER MORTALITY; CAUCASIAN; EUROPEAN AMERICAN; FEMALE; HEALTH DISPARITY; HISPANIC; HUMAN; ICD-10; ICD-9; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION SIZE; PRIORITY JOURNAL; RACE DIFFERENCE; SMOKING; SOCIAL STATUS; TRACHEA CANCER; UNITED STATES; ANCESTRY GROUP; CITY; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; LUNG TUMOR; MORTALITY; SOCIAL CLASS; SOCIOECONOMICS;

AFRICAN AMERICANS; CITIES; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; LUNG NEOPLASMS; SOCIAL CLASS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84949786259     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2015.10.003     Document Type: Article

References (63)

1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2015. CA Cancer J. Clin. 2015, 65(1):5-29.
2. Zheng L., Enewold L., Zahm S.H., Shriver C.D., Zhou J., Marrogi A., McGlynn K.A., Zhu K. Lung cancer survival among black and white patients in an equal access health system. Cancer Epidemiol. Biomarkers Prev. 2012, 21(10):1841-1847.
3. Hayanga A.J., Zeliadt S.B., Backhus L.M. Residential segregation and lung cancer mortality in the United States. JAMA Surg. 2013, 148(1):37-42.
4. Aizer A.A., Wilhite T.J., Chen M.H., Graham P.L., Choueiri T.K., Hoffman K.E., Martin N.E., Trinh Q.D., Hu J.C., Nguyen P.L. Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer 2014, 120(10):1532-1539.
5. Wingo P.A., Ries L.A., Giovino G.A., Miller D.S., Rosenberg H.M., Shopland D.R., Thun M.J., Edwards B.K. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J. Natl. Cancer Inst. 1999, 91(8):675-690.
6. Wu L.Y., Semenya K.A., Hardy R.E., Hargreaves M.K., Robinson S.B., Pederson L., Sung J.F., Haynes M.A. Cancer rate differentials between blacks and whites in three metropolitan areas: a 10-year comparison. J. Natl. Med. Assoc. 1998, 90(7):410-416.
7. Cooley M.E., Jennings-Dozier K. Lung cancer in African Americans. A call for action. Cancer Pract. 1998, 6(2):99-106.
8. Stewart J.H. Lung carcinoma in African Americans: a review of the current literature. Cancer 2001, 91(12):2476-2482.
9. Murphy S.L., Xu J., Kochanek K.D. Deaths final data for 2010. Natl. Vital Stat. Rep. 2013, 61(4):1-117.
10. Underwood J.M., Townsend J.S., Tai E., Davis S.P., Stewart S.L., White A., Momin B., Fairley T.L. Racial and regional disparities in lung cancer incidence. Cancer 2012, 118(7):1910-1918.
11. Recent trends in mortality rates for four major cancers, by sex and race/ethnicity-United States, 1990-1998. MMWR Morb Mortal Wkly Rep. 2002;51(3):49-53.
12. Top 50 Cities in the U.S. by Population and Rank, 1990,2000, 2005, 2010 and 2013. 2013 May 16. Available from: . http://www.infoplease.com/ipa/A0763098.html.
13. Hoyert D.L., Heron M.P., Murphy S.L., Kung H.C. Deaths final data for 2003. Natl. Vital Stat. Rep. 2003, 54(13):1-120.
14. Gebreab S.Y., Diez Roux A.V. Exploring racial disparities in CHD mortality between blacks and whites across the United States: a geographically weighted regression approach. Health Place 2012, 18(5):1006-1014.
15. Klein R.J., Schoenborn C.A. Age adjustment using the 2000 projected U. S. population. Healthy People 2010. Stat. Notes 2001, 20:1-10.
16. Achievements in Public Health, 1900-1999: Tobacco Use-United States, 1900-1999. MMWR Morb Mortal Wkly Rep. 2015;48(43):986-993.
17. National Center for Health Statistics. Mortality-All County (micro-data) (1990-2009), as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program.
18. Kleinbaum D., Kupper L., Morgenstern H. Epidemiologic Research Principles and Quantitative Methods 1982, California Lifetime Learning Publications, Belmont.
19. Gamble V.N., Stone D. U.S. policy on health inequities: the interplay of politics and research. J. Health Polit. Policy Law 2006, 31(1):93-126.
20. Institute S.A.S. SAS: Version 9.2 for Windows 2002-2008, SAS Institute Inc., Cary (NC).
21. US 2010. Residential segregation data: exposure and isolation indices based on 2005-2009 ACS census data. 2014 May 13. Available from: . http://www.s4.brown.edu/us2010/Data/Download1.htm.
22. Support for Community Health Workers to Increase Health Access and to Reduce Health Inequities Washington (DC): American Public Health Association, 2009; Contract No.: Policy no. 20091.
23. Jemal A., Thun M.J., Ries L.A., Howe H.L., Weir H.K., Center M.M., Ward E., Wu X.C., Eheman C., Anderson R., Ajani U.A., Kohler B., Edwards B.K. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J. Natl. Cancer Inst. 2008, 100(23):1672-1694.
24. King T.E., Brunetta P. Racial disparity in rates of surgery for lung cancer. N. Engl. J. Med. 1999, 341(16):1231-1233.
25. Fiore M.C. Trends in cigarette smoking in the United States: the epidemiology of tobacco use. Med. Clin. North Am. 1992, 76(2):289-303.
26. Bacio G.A., Guzman I.Y., Shapiro J.R., Ray L.A. Differences in quit attempts between non-Hispanic Black and White daily smokers: the role of smoking motives. Addict. Behav. 2014, 39(12):1769-1772.
27. Gadgeel S.M., Kalemkerian G.P. Racial differences in lung cancer. Cancer Metastasis Rev. 2003, 22(1):39-46.
28. Efird J.T., Landrine H., Shiue K.Y., O'Neal W.T., Podder T., Rosenman J.G., Biswas T. Race, insurance type, and stage of presentation among lung cancer patients. SpringerPlus 2014, 3:710.
29. Lehto R.H. Lung cancer screening guidelines. The nurse's role in patient education and advocacy. Clin. J. Oncol. Nurs. 2014, 18(3):338-342.
30. Graham M.V., Geitz L.M., Byhardt R., Asbell S., Roach M., 3rd, Urtasun R.C., Curran W.J., Lattin P., Russell A.H., Cox J.D. Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer. J. Natl. Cancer Inst. 1992, 84(22):1731-1735.
31. Margolis M.L., Christie J.D., Silvestri G.A., Kaiser L., Santiago S., Hansen-Flaschen J. Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann. Intern. Med. 2003, 139(7):558-563.
32. Farjah F., Wood D.E., Yanez N.D., Vaughan T.L., Symons R.G., Krishnadasan B., Flum D.R. Racial disparities among patients with lung cancer who were recommended operative therapy. Arch. Surg. 2009, 144(1):14-18.
33. Hardy D., Liu C.C., Xia R., Cormier J.N., Chan W., White A., Burau K., Du X.L. Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer. Cancer 2009, 115(10):2199-2211.
34. Mulligan C.R., Meram A.D., Proctor C.D., Wu H., Zhu K., Marrogi A.J. Unlimited access to care: effect on racial disparity and prognostic factors in lung cancer. Cancer Epidemiol. Biomarkers Prev. 2006, 15(1):25-31.
35. Lathan C.S., Neville B.A., Earle C.C. Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer. J. Clin. Oncol. 2008, 26(26):4347-4352.
36. Dimick J., Ruhter J., Sarrazin M.V., Birkmeyer J.D. Black patients more likely than whites to undergo surgery at low-quality hospitals in segregated regions. Health Aff. 2013, 32(6):1046-1053.
37. Cooper-Patrick L., Gallo J.J., Gonzales J.J., Vu H.T., Powe N.R., Nelson C., Ford D.E. Race, gender, and partnership in the patient-physician relationship. JAMA 1999, 282(6):583-589.
38. Komaromy M., Grumbach K., Drake M., Vranizan K., Lurie N., Keane D., Bindman A.B. The role of black and Hispanic physicians in providing health care for underserved populations. N. Engl. J. Med. 1996, 334(20):1305-1310.
39. Kendzor D.E., Businelle M.S., Mazas C.A., Cofta-Woerpel L.M., Reitzel L.R., Vidrine J.I., Li Y., Costello T.J., Cinciripini P.M., Ahluwalia J.S., Wetter D.W. Pathways between socioeconomic status and modifiable risk factors among African American smokers. J. Behav. Med. 2009, 32(6):545-557.
40. Laveist T.A., Thorpe R.J., Mance G.A., Jackson J. Overcoming confounding of race with socio-economic status and segregation to explore race disparities in smoking. Addiction 2007, 102(Suppl. 2):65-70.
41. US Department of Health and Human Services Healthy People 2010. With Understanding and Improving Health and Objectives for Improving Health 2000, vol. 2. US Government Printing Office, Washington, D. C. 2nd ed.
42. Jamal A., Agaku I.T., O'Connor E., King B.A., Kenemer J.B., Neff L. Current cigarette smoking among adults-United States, 2005-2013. MMWR Morb. Mortal. Wkly. Rep. 2014, 63(47):1108-1112.
43. Centers for Disease Contro and Prevention.Best Practices for Comprehensive Tobacco Control Programs 2014, 2014. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta.
44. Cokkinides V.E., Halpern M.T., Barbeau E.M., Ward E., Thun M.J. Racial and ethnic disparities in smoking-cessation interventions: analysis of the 2005 National Health Interview Survey. Am. J. Prev. Med. 2008, 34(5):404-412.
45. Irvin Vidrine J., Reitzel L.R., Wetter D.W. The role of tobacco in cancer health disparities. Curr. Oncol. Rep. 2009, 11(6):475-481.
46. Lopez-Quintero C., Crum R.M., Neumark Y.D. Racial/ethnic disparities in report of physician-provided smoking cessation advice: analysis of the 2000 National Health Interview Survey. Am. J. Public Health 2006, 96(12):2235-2239.
47. Institute of Medicine Ending the Tobacco Problem: A Blueprint for the Nation 2007, National Academies Press, Washington, D. C.
48. Lubetkin E.I., Lu W.H., Krebs P., Yeung H., Ostroff J.S. Exploring primary care providers' interest in using patient navigators to assist in the delivery of tobacco cessation treatment to low income, ethnic/racial minority patients. J. Commun. Health 2010, 35(6):618-624.
49. Andrews J.O., Felton G., Ellen Wewers M., Waller J., Tingen M. The effect of a multi-component smoking cessation intervention in African American women residing in public housing. Res. Nurs. Health 2007, 30(1):45-60.
50. U.S.Department of Health and Human Services Treating Tobacco Use and Dependence: 2008 Update 2008, US Department of Health and Human Services, Washington DC.
51. Silagy C., Lancaster T., Stead L., Mant D., Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. 2004, 3:CD000146.
52. Singleterry J., Jump Z., Lancet E., Babb S., MacNeil A., Zhang L. State medicaid coverage for tobacco cessation treatments and barriers to coverage-United States, 2008-2014. MMWR Morb. Mortal. Wkly. Rep. 2014, 264-269.
53. L. Humphrey, M. Deffebach, M. Pappas, C. Baumann, K. Artis, J.P. Mitchell, B. Zakher, R. Fu, C. Slatore. Screening for Lung Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation. Rockville MD. (2013).
54. Moyer V.A. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 2014, 160(5):330-338.
55. The Centers for Medicare & Medicaid Services (CMS). Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG-00439N). 2015 May 5. Available from: . http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx%3FNCAId=274.
56. Peek M.E., Han J.H. Disparities in screening mammography. Current status, interventions and implications. J. Gen. Intern. Med. 2004, 19(2):184-194.
57. Wells K.J., Luque J.S., Miladinovic B., Vargas N., Asvat Y., Roetzheim R.G., Kumar A. Do community health worker interventions improve rates of screening mammography in the United States? A systematic review. Cancer Epidemiol. Biomarkers Prev. 2011, 20(8):1580-1598.
58. Percac-Lima S., Grant R.W., Green A.R., Ashburner J.M., Gamba G., Oo S., Richter J.M., Atlas S.J. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J. Gen. Intern. Med. 2009, 24(2):211-217.
59. Bese N.S., Hendry J., Jeremic B. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int. J. Radiat. Oncol. Biol. Phys. 2007, 68(3):654-661.
60. Zhao H., Zhu W., Xie P., Li H., Zhang X., Sun X., Yu J., Xing L. A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer. Radiother. Oncol. 2014, 110(1):132-136.
61. Robinson-White S., Conroy B., Slavish K.H., Rosenzweig M. Patient navigation in breast cancer: a systematic review. Cancer Nurs. 2010, 33(2):127-140.
62. Wells K.J., Battaglia T.A., Dudley D.J., Garcia R., Greene A., Calhoun E., Mandelblatt J.S., Paskett E.D., Raich P.C. Patient navigation: state of the art or is it science?. Cancer 2008, 113(8):1999-2010.
63. Hunt B.R., Whitman S., Hurlbert M.S. Increasing Black White disparities in breast cancer mortality in the 50 largest cities in the United States. Cancer Epidemiol. 2014, 38(2):118-123.